You are here:
For more info, contact GAVI country representative officer or email here
Red line on table indicates duration of support based on commitments. Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year. Approvals: Total Approved for funding (IRC Reviewed)
Download data for commitments & disbursements in XLS format
Data refers to disbursed values, date as per above chart
Move mouse over graph for details
08 March 2012
GAVI recognised for work to accelerate introduction of HPV vaccines in developing countries
New York-based Women Deliver highlights potential benefits of HPV vaccine for as many as 28 million girls in developing countries by 2020. [日本語]
21 February 2012
Q and A on Nigeria’s introduction of MenAfriVac
Interview with Muhammad Sani Adamu, Head of Accelerated Disease Control in Nigeria’s National Primary Health Care Development Agency, who played a key role in rolling out the new vaccine against meningitis A, MenAfriVac, to Nigeria’s northern states.
26 January 2012
Chad’s campaign against meningitis A
One of the first countries to introduce the new meningitis A vaccine (MenAfriVac), Chad ran an immunisation campaign with GAVI support in December 2011 to help eliminate the region’s devastating epidemics.
modal window here
